Capricor Therapeutics | CAPR - Assets


Capricor Therapeutics reported $368.74M in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Bioline Rx USD 33.48M 5.32M Jun/2026
Capricor Therapeutics USD 368.74M 42.45M Jun/2026
Cipla INR 434.34B 9.38B Sep/2026
Cytokinetics USD 1.82B 99.77M Sep/2026
Geron USD 527.11M 8.1M Sep/2026
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 189.74M 165.69M Mar/2026
J&J USD 197.42B 3.64B Sep/2026
Plus Therapeutics USD 14.03M 5.89M Jun/2026
Prothena USD 283.52M 19.06M Sep/2026
PTC Therapeutics USD 3.21B 42.76M Sep/2026
Sarepta Therapeutics USD 3.17B 22.45M Sep/2026